Abstract Details

Title Reversal of allodynia and neurophysiological outcomes by CX-8998, a potent, selective T-type calcium channel modulator, in a model of bortezomib induced peripheral neurotoxicity

Topic Pain

Presentation(s) S7 - (-)

Poster/Presentation
Number 004

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Margaret S. Lee, PhD PRESENTER	No disclosure on file
Yuri Maricich	No disclosure on file
Guido Cavaletti	No disclosure on file
Spyridon Papapetropoulos, MD, PhD (SPIRIDON PAPAPETROPOULOS, MD, PHD)	Dr. Papapetropoulos has received personal compensation for serving as an employee of Vigil Neuroscience . Dr. Papapetropoulos has received personal compensation for serving as an employee of Bionomics Ltd. Dr. Papapetropoulos has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Lipocine Inc. Dr. Papapetropoulos has stock in Vigil Neuroscience. Dr. Papapetropoulos has stock in Lipocine. Dr. Papapetropoulos has stock in Bionomics Ltd.